Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.
Bone Therapeutics is a international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's uniqueknowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products,tailored in-house production methods, and minimally invasive treatment techniques.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 1, 2021 | Post-IPO Debt | €16M | 1 | European Investment Bank | — | Detail |
Jan 28, 2013 | Series D | €7.70M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Post-IPO Debt |
Nausicaa Ventures | — | Series D |